Prognostic Prediction Model of Patients With AcUte Stroke undeRgoing EndOvascular TheRApy (AURORA)

Recruiting Observational Study
Acute Ischemic Stroke
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Observational
Participants needed
949 (estimated)
Sponsor
Beijing Tiantan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Stroke is the leading cause of disability-adjusted life years (DALYs) in China, imposing a heavy burden on society and families. Endovascular therapy (EVT) has opened the 2.0 era of acute ischemic stroke (AIS) treatment, but still up to 1/3 of patients have poor neurological prognosis. The results of several studies at home and abroad and by our team indicate that anesthesia method and perioperati…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years; * NIHSS score ≥4; * Image-confirmed (CTA/MRA/DSA) intracranial large artery occlusion; * ASPECT (anterior circulation) or PC-ASPECT (posterior circulation) score ≥3; * Endovascular treatment including arterial thrombolysis, mechanical thrombolysis, and angioplas…
Contacts

Ruquan Han

8610-59976660

ruquan.han@gmail.com

CONTACT

Fa Liang

8610-59976658

liangfa1001@163.com

CONTACT